| Description | This summary outlines the potential role of a widely available drug (misoprostol) in reducing deaths from postpartum hemorrhage, and describes an initiative to evaluate misoprostol as an alternative therapy for postpartum hemorrhage prevention and treatment. The document lists the potential advantages of misoprostol (as compared to standard treatments) in resource-constrained settings, describes the rationale, objectives, and protocols related to the research efforts, and outlines a set of related project activities to shape policy and share information in support of misoprostol for postpartum hemorrhage. |
